Request Free Sample ×
US Outdoor Performance Apparel Market Research Report - Forecast Till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Outdoor Performance Apparel Market

ID: MRFR/CG/12298-HCR
128 Pages
Tejas Chaudhary
Last Updated: April 06, 2026

US Outdoor Performance Apparel Market Size, Share, Industry Trend & Analysis Research Report By Product Type (Jackets & Vests, Pants & Trousers, Boots & Shoes, Base Layers, Compression Wear, Others), By Fabric Type (Woven, Knit), By Material (Natural, Synthetic), By End-User (Recreational, Professional), By Price Range (Economy/Mass, Premium), By Fabric Category (Running, Swimming & Water Sports, Cycling, Ski & Snow, Hunting & Fishing, Others), By Consumer (Men, Women, Children) andBy Distribution Channel (Store-based, Non-store-based)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Outdoor Performance Apparel Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Product Type (USD Million)
  49.     4.1.1 Jackets & Vests
  50.     4.1.2 Pants & Trousers
  51.     4.1.3 Boots & Shoes
  52.     4.1.4 Base Layers
  53.     4.1.5 Compression Wear
  54.     4.1.6 Others
  55.   4.2 Pharmaceutical, BY Fabric Type (USD Million)
  56.     4.2.1 Woven
  57.     4.2.2 Knit
  58.   4.3 Pharmaceutical, BY Material (USD Million)
  59.     4.3.1 Natural
  60.     4.3.2 Synthetic
  61.   4.4 Pharmaceutical, BY End-User (USD Million)
  62.     4.4.1 Recreational
  63.     4.4.2 Professional
  64.   4.5 Pharmaceutical, BY Price Range (USD Million)
  65.     4.5.1 Economic/Mass
  66.     4.5.2 Premium
  67.   4.6 Pharmaceutical, BY Fabric Category (USD Million)
  68.     4.6.1 Running
  69.     4.6.2 Swimming & Water Sports
  70.     4.6.3 Cycling
  71.     4.6.4 Ski & Snow
  72.     4.6.5 Hunting & Fishing
  73.     4.6.6 Others
  74.   4.7 Pharmaceutical, BY Consumer (USD Million)
  75.     4.7.1 Men
  76.     4.7.2 Women
  77.     4.7.3 Children
  78.   4.8 Pharmaceutical, BY Distribution Channel (USD Million)
  79.     4.8.1 Store-based
  80.     4.8.2 Non-store-based
  81. 5 SECTION V: COMPETITIVE ANALYSIS
  82.   5.1 Competitive Landscape
  83.     5.1.1 Overview
  84.     5.1.2 Competitive Analysis
  85.     5.1.3 Market share Analysis
  86.     5.1.4 Major Growth Strategy in the Pharmaceutical
  87.     5.1.5 Competitive Benchmarking
  88.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  89.     5.1.7 Key developments and growth strategies
  90.       5.1.7.1 New Product Launch/Service Deployment
  91.       5.1.7.2 Merger & Acquisitions
  92.       5.1.7.3 Joint Ventures
  93.     5.1.8 Major Players Financial Matrix
  94.       5.1.8.1 Sales and Operating Income
  95.       5.1.8.2 Major Players R&D Expenditure. 2023
  96.   5.2 Company Profiles
  97.     5.2.1 Nike (US)
  98.       5.2.1.1 Financial Overview
  99.       5.2.1.2 Products Offered
  100.       5.2.1.3 Key Developments
  101.       5.2.1.4 SWOT Analysis
  102.       5.2.1.5 Key Strategies
  103.     5.2.2 Adidas (DE)
  104.       5.2.2.1 Financial Overview
  105.       5.2.2.2 Products Offered
  106.       5.2.2.3 Key Developments
  107.       5.2.2.4 SWOT Analysis
  108.       5.2.2.5 Key Strategies
  109.     5.2.3 The North Face (US)
  110.       5.2.3.1 Financial Overview
  111.       5.2.3.2 Products Offered
  112.       5.2.3.3 Key Developments
  113.       5.2.3.4 SWOT Analysis
  114.       5.2.3.5 Key Strategies
  115.     5.2.4 Columbia Sportswear (US)
  116.       5.2.4.1 Financial Overview
  117.       5.2.4.2 Products Offered
  118.       5.2.4.3 Key Developments
  119.       5.2.4.4 SWOT Analysis
  120.       5.2.4.5 Key Strategies
  121.     5.2.5 Patagonia (US)
  122.       5.2.5.1 Financial Overview
  123.       5.2.5.2 Products Offered
  124.       5.2.5.3 Key Developments
  125.       5.2.5.4 SWOT Analysis
  126.       5.2.5.5 Key Strategies
  127.     5.2.6 Under Armour (US)
  128.       5.2.6.1 Financial Overview
  129.       5.2.6.2 Products Offered
  130.       5.2.6.3 Key Developments
  131.       5.2.6.4 SWOT Analysis
  132.       5.2.6.5 Key Strategies
  133.     5.2.7 Arc'teryx (CA)
  134.       5.2.7.1 Financial Overview
  135.       5.2.7.2 Products Offered
  136.       5.2.7.3 Key Developments
  137.       5.2.7.4 SWOT Analysis
  138.       5.2.7.5 Key Strategies
  139.     5.2.8 Marmot (US)
  140.       5.2.8.1 Financial Overview
  141.       5.2.8.2 Products Offered
  142.       5.2.8.3 Key Developments
  143.       5.2.8.4 SWOT Analysis
  144.       5.2.8.5 Key Strategies
  145.     5.2.9 Mountain Hardwear (US)
  146.       5.2.9.1 Financial Overview
  147.       5.2.9.2 Products Offered
  148.       5.2.9.3 Key Developments
  149.       5.2.9.4 SWOT Analysis
  150.       5.2.9.5 Key Strategies
  151.   5.3 Appendix
  152.     5.3.1 References
  153.     5.3.2 Related Reports
  154. 6 LIST OF FIGURES
  155.   6.1 MARKET SYNOPSIS
  156.   6.2 US MARKET ANALYSIS BY PRODUCT TYPE
  157.   6.3 US MARKET ANALYSIS BY FABRIC TYPE
  158.   6.4 US MARKET ANALYSIS BY MATERIAL
  159.   6.5 US MARKET ANALYSIS BY END-USER
  160.   6.6 US MARKET ANALYSIS BY PRICE RANGE
  161.   6.7 US MARKET ANALYSIS BY FABRIC CATEGORY
  162.   6.8 US MARKET ANALYSIS BY CONSUMER
  163.   6.9 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  164.   6.10 KEY BUYING CRITERIA OF PHARMACEUTICAL
  165.   6.11 RESEARCH PROCESS OF MRFR
  166.   6.12 DRO ANALYSIS OF PHARMACEUTICAL
  167.   6.13 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  168.   6.14 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  169.   6.15 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  170.   6.16 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
  171.   6.17 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
  172.   6.18 PHARMACEUTICAL, BY FABRIC TYPE, 2024 (% SHARE)
  173.   6.19 PHARMACEUTICAL, BY FABRIC TYPE, 2024 TO 2035 (USD Million)
  174.   6.20 PHARMACEUTICAL, BY MATERIAL, 2024 (% SHARE)
  175.   6.21 PHARMACEUTICAL, BY MATERIAL, 2024 TO 2035 (USD Million)
  176.   6.22 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
  177.   6.23 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
  178.   6.24 PHARMACEUTICAL, BY PRICE RANGE, 2024 (% SHARE)
  179.   6.25 PHARMACEUTICAL, BY PRICE RANGE, 2024 TO 2035 (USD Million)
  180.   6.26 PHARMACEUTICAL, BY FABRIC CATEGORY, 2024 (% SHARE)
  181.   6.27 PHARMACEUTICAL, BY FABRIC CATEGORY, 2024 TO 2035 (USD Million)
  182.   6.28 PHARMACEUTICAL, BY CONSUMER, 2024 (% SHARE)
  183.   6.29 PHARMACEUTICAL, BY CONSUMER, 2024 TO 2035 (USD Million)
  184.   6.30 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  185.   6.31 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  186.   6.32 BENCHMARKING OF MAJOR COMPETITORS
  187. 7 LIST OF TABLES
  188.   7.1 LIST OF ASSUMPTIONS
  189.     7.1.1
  190.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  191.     7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  192.     7.2.2 BY FABRIC TYPE, 2025-2035 (USD Million)
  193.     7.2.3 BY MATERIAL, 2025-2035 (USD Million)
  194.     7.2.4 BY END-USER, 2025-2035 (USD Million)
  195.     7.2.5 BY PRICE RANGE, 2025-2035 (USD Million)
  196.     7.2.6 BY FABRIC CATEGORY, 2025-2035 (USD Million)
  197.     7.2.7 BY CONSUMER, 2025-2035 (USD Million)
  198.     7.2.8 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  199.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  200.     7.3.1
  201.   7.4 ACQUISITION/PARTNERSHIP
  202.     7.4.1

US Pharmaceutical Market Segmentation

Pharmaceutical By Product Type (USD Million, 2025-2035)

  • Jackets & Vests
  • Pants & Trousers
  • Boots & Shoes
  • Base Layers
  • Compression Wear
  • Others

Pharmaceutical By Fabric Type (USD Million, 2025-2035)

  • Woven
  • Knit

Pharmaceutical By Material (USD Million, 2025-2035)

  • Natural
  • Synthetic

Pharmaceutical By End-User (USD Million, 2025-2035)

  • Recreational
  • Professional

Pharmaceutical By Price Range (USD Million, 2025-2035)

  • Economic/Mass
  • Premium

Pharmaceutical By Fabric Category (USD Million, 2025-2035)

  • Running
  • Swimming & Water Sports
  • Cycling
  • Ski & Snow
  • Hunting & Fishing
  • Others

Pharmaceutical By Consumer (USD Million, 2025-2035)

  • Men
  • Women
  • Children

Pharmaceutical By Distribution Channel (USD Million, 2025-2035)

  • Store-based
  • Non-store-based

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓